Chargement en cours...
The Cost-Effectiveness of Vedolizumab for Inflammatory Bowel Disease: A Review of the Current Literature
The United States spends a greater share per gross domestic product on health care than any other developed country in the world. Cost-conscious, high-value care has an important role in the practice of medicine. Inflammatory bowel disease (IBD) affects 1.6 million people in the United States and is...
Enregistré dans:
| Publié dans: | Gastroenterol Hepatol (N Y) |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Millennium Medical Publishing
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5114504/ https://ncbi.nlm.nih.gov/pubmed/27917076 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|